Recombinant Anti-TRK fused gene antibody [EPR8766] - BSA and Azide free (ab235871)


  • Product name

    Anti-TRK fused gene antibody [EPR8766] - BSA and Azide free
    See all TRK fused gene primary antibodies
  • Description

    Rabbit monoclonal [EPR8766] to TRK fused gene - BSA and Azide free
  • Host species

  • Tested applications

    Suitable for: WB, IP, IHC-P, ICC/IFmore details
    Unsuitable for: Flow Cyt
  • Species reactivity

    Reacts with: Mouse, Rat, Human
  • Immunogen

    Synthetic peptide within Human TRK fused gene. The exact sequence is proprietary.

  • Positive control

    • Human fetal brain, HeLa, A549, MCF-7 and 293T cell lysates; Human colon tissue and Human thyroid carcinoma tissue; HeLa cells.
  • General notes

    Ab235871 is the carrier-free version of ab156866. This format is designed for use in antibody labeling, including fluorochromes, metal isotopes, oligonucleotides, enzymes.


    Our carrier-free formats are supplied in a buffer free of BSA, sodium azide and glycerol for higher conjugation efficiency.

    Use our conjugation kits  for antibody conjugates that are ready-to-use in as little as 20 minutes with <1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.

    ab235871 is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm.

    Maxpar® is a trademark of Fluidigm Canada Inc.



Our Abpromise guarantee covers the use of ab235871 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB Use at an assay dependent concentration. Predicted molecular weight: 43 kDa.
IP Use at an assay dependent concentration.
IHC-P Use at an assay dependent concentration. Perform heat mediated antigen retrieval before commencing with IHC staining protocol.
ICC/IF Use at an assay dependent concentration.
  • Application notes
    Is unsuitable for Flow Cyt.
  • Target

    • Tissue specificity

    • Involvement in disease

      Defects in TFG are a cause of thyroid papillary carcinoma (TPC) [MIM:188550]. TPC is a common tumor of the thyroid that typically arises as an irregular, solid or cystic mass from otherwise normal thyroid tissue. Papillary carcinomas are malignant neoplasm characterized by the formation of numerous, irregular, finger-like projections of fibrous stroma that is covered with a surface layer of neoplastic epithelial cells. Note=A chromosomal aberration involving TFG is found in thyroid papillary carcinomas. Translocation t(1;3)(q21;q11) with NTRK1. The TFG sequence is fused to the 3'-end of NTRK1 generating the TRKT3 (TRK-T3) fusion transcript.
    • Information by UniProt
    • Database links

    • Alternative names

      • FLJ36137 antibody
      • HMSNP antibody
      • OTTHUMP00000214045 antibody
      • OTTHUMP00000214046 antibody
      • OTTHUMP00000214047 antibody
      • OTTHUMP00000214048 antibody
      • Protein TFG antibody
      • SPG57 antibody
      • TF6 antibody
      • TFG antibody
      • TFG_HUMAN antibody
      • TRK fused antibody
      • TRK fused gene antibody
      • TRK fused gene protein antibody
      • TRK-fused gene protein antibody
      • TRKT3 antibody
      • TRKT3 oncogene antibody
      see all


    ab235871 has not yet been referenced specifically in any publications.

    Customer reviews and Q&As

    There are currently no Customer reviews or Questions for ab235871.
    Please use the links above to contact us or submit feedback about this product.

    For licensing inquiries, please contact

    Sign up